Search Results (247)

Underwater object detection plays a vital role in marine exploration and resource exploitation. However, complex underwater environment leads to severe color deviation, blurring, and information loss of small targets, which greatly restrict detection performance. To address these problems, this paper integrates the Channel Attention and Spatial Attention Block (CASAB) attention mechanism into residual blocks based on generative adversarial networks to correct color distortion and improve the clarity of degraded underwater images. For underwater small object detection, MobileNetV2 is selected as the backbone network within the Faster R-CNN framework, and a multi-scale feature fusion strategy is adopted to reduce feature loss caused by repeated downsampling. In the detection head, coordinate attention and parallel dilated convolution are further integrated to suppress background noise and expand the receptive field of feature extraction. Experimental results on the Underwater Robot Professional Contest (URPC) dataset demonstrate that the proposed method yields gains of 10.06%, 9.43%, and 12.29% in three evaluation metrics: Underwater Image Quality Measure (UIQM), Underwater Colour Image Quality Evaluation (UCIQE) and Natural Image Quality Evaluator (NIQE), together with 7.81% in Mean Average Precision (mAP) and an 8.57% increase in Mean Recall (mRecall). These results demonstrate the effectiveness of all improvements. Full article

Railway screw couplings are safety-critical, yet service failures show fatigue cracking at geometric discontinuities. This work assesses the response of two UIC screw-coupling components—the shackle and trunnion—under longitudinal forces from Traction–Emergency Braking (TEB) manoeuvres. A linear-elastic 3D finite element model was built for 42CrMo4/AISI 4140 steel, idealising the threaded load transfer with an RBE2 condensation and the hook–shackle interface with a tied contact to provide a repeatable baseline. Longitudinal force histories were generated in TrainDy for a freight consist and mapped to Regions of Interest; fatigue was evaluated in Altair HyperLife using rainflow counting, Goodman mean-stress correction, and Palmgren–Miner accumulation on a uniaxial S-N curve. For the 636 kN envelope case, the model predicts an axial displacement of 0.985 mm and von Mises stresses in several relevant regions near the nominal yield strength. Fatigue results rank the trunnion pin fillet as the governing hotspot: representative TEB sequences yield damage indices greater than 1 (often of order 20), while a lower-amplitude braking block shows negligible damage. Overall, the analysed spectra leave little endurance margin for the current geometry and support redesign of critical radii and more realistic contact/boundary modelling. Full article

Rubus buergeri Miq., a wild species native to Jeju Island (Republic of Korea), is a relatively understudied plant with potential as a source of bioactive phenolic compounds. This study investigated the phytochemical composition of R. buergeri extract (RBE) and evaluated its antioxidant and anti-inflammatory activities using a bioactivity-guided fractionation approach. Antioxidant capacity was assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and ferric reducing antioxidant power assays (FRAP), along with total phenolic content determination, while anti-inflammatory activity was evaluated by measuring nitric oxide (NO) production and inflammatory gene expression in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. RBE exhibited high phenolic content and strong antioxidant activity; its ethyl acetate and n-butanol fractions demonstrated the greatest antioxidant activities and significantly inhibited LPS-induced NO production. Furthermore, RBE suppressed LPS-induced mRNA expression of Nos2, Ptgs2, Tnfa, Il1b, and Il6, indicating coordinated inhibition of inflammatory responses. Ultra-high-performance liquid chromatography (UHPLC) analysis identified ellagic acid, ethyl gallate, and epicatechin as major phenolic constituents, with ellagic acid and ethyl gallate showing stronger inhibitory effects on NO production and inflammatory gene expression than epicatechin. These findings suggest that the phenolic constituents of R. buergeri modulate NO-associated inflammatory responses and support its potential as a source of anti-inflammatory phytochemicals. Full article

Cholangiocarcinoma (CCA) is an aggressive malignancy with a poor prognosis that is strongly associated with chronic Clonorchis sinensis (C. sinensis, Cs) infection; however, its underlying molecular mechanisms remain elusive. Recent studies suggest that C. sinensis-derived extracellular vesicles (CsEVs) play a crucial role in host–parasite interactions and in shaping the tumor microenvironment during infection. Acting as key delivery vehicles, these CsEVs can transfer specific functional molecules, such as microRNAs (miRNAs), to host cholangiocytes, thereby modulating cellular behaviors—a process that may represent a significant pathway in parasite-induced carcinogenesis. Despite this, the specific miRNAs shuttled by CsEVs and their concrete functions and mechanisms in driving CCA proliferation and metastasis remain largely unexplored. To this end, we investigated Csi-miR-125a, a miRNA abundantly expressed in CsEVs, aiming to systematically elucidate its dual regulatory functions in CCA progression. Our findings offer novel mechanistic insights into host–parasite crosstalk, further the understanding of CCA pathogenesis, and point to potential therapeutic avenues. Using gain-and loss-of-function approaches in RBE and HuCCT1 cell lines, we demonstrated that Csi-miR-125a promotes cell proliferation by accelerating cell-cycle progression and suppressing apoptosis through direct targeting of BAK1. Concurrently, Csi-miR-125a enhances the migratory and invasive capacities of CCA cells via activation of the ERK signaling pathway. In a BALB/c nude mouse lung metastasis model, CsEVs depleted of Csi-miR-125a significantly inhibited pulmonary metastasis. Collectively, This study found that Csi-miR-125a derived from C. sinensis can regulate apoptosis and cell cycle progression by targeting BAK1, thereby promoting the proliferation of cholangiocarcinoma cells; meanwhile, it enhances cell migration and invasion by activating the ERK signaling pathway. These results suggest that Csi-miR-125a participates in and promotes the malignant progression of CCA. However, given its high homology with human endogenous miR-125a, its function may partially overlap with host endogenous miRNAs, rather than representing a completely independent carcinogenic effect. These findings provide mechanistic insights into host–parasite interactions during C. sinensis infection and lay a theoretical foundation for subsequent targeted intervention studies. Full article

Background: Radiotherapy is essential for skull base tumor management but carries the risk of radiation-induced brain injury (RIBI). This spectrum ranges from transient radiation-induced contrast enhancement (RICE) to irreversible necrosis. Distinguishing these entities from tumor progression is critical, particularly with the increasing adoption of proton therapy. Methods: A comprehensive narrative review of the peer-reviewed literature was conducted up to October 1, 2025. The search strategy focused on adult patients treated for skull base malignancies, synthesizing data on dose–volume metrics, incidence rates, and modality-specific toxicity profiles. Results: RIBI represents a pathophysiological continuum. (a) Descriptive imaging patterns: In prospective proton therapy series, focal RICE occured in 15% of patients, typically at a median of 12 months, and often resolved spontaneously. (b) Modality comparison: Although proton therapy reduces integral brain dose versus photon therapy, elevated linear energy transfer (LET) at the distal Bragg peak may contribute to focal radiation-associated image changes (RAIC), particularly in the temporal lobes. (c) Risk stratification and diagnosis: Risk increased when >1% of the healthy brain received >57.6 Gy (Relative Biological Energy (RBE)) or when V67Gy exceeded 0.17 cc. Advanced MRI and amino acid positron emission tomography (PET) improved differentiation between radiation effects and tumor recurrence. Conclusions: Post-radiation imaging changes are common and often benign. Distinguishing RICE from progression requires multimodal imaging and adherence to specific dose constraints. Management should prioritize surveillance for asymptomatic lesions. Full article

There are some methods based on the railway power conditioner (RPC) that can address the imbalance issue, improve load fluctuation, and manage the regenerative braking energy (RBE) of the traction power supply system in high-speed railways. However, the coupling of imbalance compensation and energy storage is a problem in the RPC method. Therefore, a novel decoupling control method is proposed in this paper. The topology of the method is based on a three-phase converter, and the energy storage unit is connected to the DC side of the converter. A decoupling possibility and principle analysis is carried out. The mechanism of the proposed method in coping with different working conditions of high-speed railways is introduced in detail. Then, a capacity analysis and the control method are presented. According to the theoretical analysis, while the traditional RPC requires no extra capacity under single-task operations, its required capacity increases by 15.47% under typical hybrid conditions and can even surge by over 30% under severe coupling scenarios, to achieve the same effect as the proposed decoupled method. Finally, simulations and experiments are carried out to verify the effectiveness and flexibility of the novel method. Full article

This study investigated the effects of rice bran extract (RBE) on the quality and digestibility of Chinese steamed buns (CSBs). RBE decreased the starch pasting properties, weakened the starch gel network structure, and reduced the storage modulus (G′) and loss modulus (G″). With the increase in RBE addition in CSBs, lightness difference (ΔL*) decreased, total color difference (ΔE*) increased, and the color of CSBs shifted from light to dark orange-red. Additionally, RBE increased the specific volume and enlarged the pore size of the CSBs. When 15% RBE was added, the CSBs had the lowest hardness and the highest springiness, indicating optimal quality. Notably, the addition of RBE significantly (p < 0.05) reduced the estimated glycemic index (eGI) from 90.916 ± 0.530 to 82.282 ± 0.399 at a 20% concentration, which represents a 9.5% reduction. This study provides a reference for the development of low-glycemic-index (GI) foods. Full article

Background: CDKN2A (p16^INK4a^) is integral to the regulation of the RB–E2F cell-cycle checkpoint and is widely acknowledged as a surrogate marker for high-risk human papillomavirus (HPV)-related cervical neoplasia. Nevertheless, its diagnostic and prognostic significance in uterine corpus endometrial carcinoma (UCEC), a predominantly HPV-independent malignancy, remains inadequately characterized. This study utilized an integrated multi-omics approach to examine CDKN2A dysregulation in cervical squamous cell carcinoma (CESC) and UCEC. Methods: Pan-cancer and tumor–normal differential expression analyses were performed using TIMER2.0 and GEPIA2 (TCGA/GTEx). Clinicopathological correlations were assessed with UALCAN. Protein expression patterns were analyzed using immunohistochemistry data from the Human Protein Atlas (HPA). Prognostic significance and immune-infiltration associations were evaluated using TCGA survival data and TIMER modules. Independent transcriptomic validation and diagnostic classification performance were assessed using GEO datasets GSE9750 (CESC) and GSE63678 (UCEC), including ROC-AUC analysis with cross-validation. Results: Integrated analyses revealed elevated CDKN2A expression in both CESC and UCEC across multiple transcriptomic cohorts, with pronounced tumor-specific protein expression on immunohistochemistry. TCGA-only tumor–normal RNA comparisons were non-significant, likely due to limited normal sample representation. In independent GEO cohorts, CDKN2A exhibited excellent tumor–normal discrimination in CESC (AUC = 0.982) and moderate discrimination in UCEC (AUC = 0.761). Survival analysis indicated tumor-specific patterns, with limited prognostic stratification in CESC and context-dependent associations in UCEC. Immune-infiltration analysis suggested tumor-type-specific interactions between CDKN2A expression and immune cell subsets. Conclusions: CDKN2A exhibits strong diagnostic performance in HPV-associated cervical cancer and moderate, cohort-dependent discriminatory ability in endometrial carcinoma. These findings reinforce its established diagnostic role in CESC and propose adjunctive utility in UCEC, underscoring the importance of tumor-contextual interpretation of CDKN2A expression in gynecologic malignancies. Full article

Background and Purpose: This study retrospectively evaluates the outcomes of head and neck adenoid cystic carcinomas (ACCs) treated with particle therapy, including carbon ion radiotherapy (CIRT) alone or combined with photon therapy, at a single institution. Methods and Materials: Patients with ACC who underwent CIRT alone or a combination of CIRT and photon therapy at the Marburg Ion Therapy Center between February 2017 and December 2023 were included. Radiation therapy was administered postoperatively in surgically resectable patients and as definitive treatment in unresectable patients. Newly diagnosed patients received CIRT as a boost in combination with photon intensity-modulated radiation therapy (IMRT), while those with recurrent disease received CIRT alone. Prognostic factors were analyzed using Kaplan–Meier analysis and proportional hazards regression for multiple regression. Late toxicities (grade 3 or higher) were recorded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 4. Results: A total of 73 patients were included, with a median age of 57 years (range: 16–86 years) and a median follow-up of 20 months (range: 3–70 months). The cohort included 28 males (38%) and 45 females (62%). The median CIRT dose was 24 Gy (relative biological effectiveness (RBE)) (range: 15–60 Gy) in a median of 8 fractions (range: 5–20), and the median photon dose was 50 Gy (range: 45–54 Gy) in 25 fractions (range: 15–30). Locoregional recurrence-free survival rates at 1 and 3 years were 89.6% and 75.4%, respectively, while distant metastasis-free survival rates were 82.1% and 61.4%, respectively. LC was significantly influenced by T stage, with patients with T4 tumors showing worse outcomes. Treatment was generally well tolerated, with acute side effects including mucositis and skin erythema. Severe chronic toxicities were rare, with only 1% of patients experiencing grade 3 dysphagia and grade 3 xerostomia. Conclusions: CIRT, particularly when combined with photon therapy, demonstrates favorable local control and promising efficacy in head and neck ACC, though distant metastasis remains the primary pattern of failure. Tumor stage is a significant negative prognostic factor for local control and overall survival. Full article

Boron neutron capture therapy (BNCT) is a binary radiotherapy that is based on nuclear reactions between boron-10 and low-energy neutrons, which enables selective tumor cell killing. Although accelerator-based BNCT systems are increasingly being adopted, each platform requires independent biological validation. Here, we performed an in vitro preclinical evaluation of the linac-based iBNCT001 system employing a beryllium target in combination with the clinically approved boron drug SPM-011 (borofalan (¹⁰B)). Three complementary studies were conducted: (i) a cell-based BNCT efficacy study, (ii) a free-beam radiobiological evaluation, and (iii) a radiation leakage assessment using a human-phantom model. BNCT using iBNCT001 and SPM-011 induced clear boron concentration- and dose-dependent reductions in clonogenic survival across multiple tumor cell lines. Free-beam experiments determined a relative biological effectiveness (RBE) of 2.3 for the hydrogen dose component associated with high energy neutrons. In the phantom study, the maximum radiation leakage dose during head irradiation was 1.31 GyEq in the cervical region. Although this study is limited to in vitro biological assessments, the results provide non-clinical evidence supporting the efficacy, beam quality, and biological safety of iBNCT001 for future clinical BNCT applications. Full article

Actinium-225 (²²⁵Ac) has emerged as a pivotal alpha-emitter in modern radiopharmaceutical therapy, offering potent cytotoxicity with the potential for precise tumour targeting. Accurate, patient-specific image-based dosimetry for ²²⁵Ac is essential to optimize therapeutic efficacy while minimizing radiation-induced toxicity. Establishing a robust dosimetry workflow is particularly challenging due to the complex decay chain, low administered activity, limited count statistics, and the indirect measurement of daughter gamma emissions. Clinical single-photon emission computed tomography/computed tomography protocols with harmonized acquisition parameters, combined with robust volume-of-interest segmentation, artificial intelligence (AI)-driven image processing, and voxel-level analysis, enable reliable time-activity curve generation and absorbed-dose calculation, while reduced mixed-model approaches improve workflow efficiency, reproducibility, and patient-centred implementation. Cadmium zinc telluride-based gamma cameras further enhance quantitative accuracy, enabling rapid whole-body imaging and precise activity measurement, supporting patient-friendly dosimetry. Complementing these advances, the cerium-134/lanthanum-134 positron emission tomography in vivo generator provides a unique theranostic platform to noninvasively monitor ²²⁵Ac progeny redistribution, evaluate alpha-decay recoil, and study tracer internalization, particularly for internalizing vectors. Together, these technological and methodological innovations establish a mechanistically informed framework for individualized ²²⁵Ac dosimetry in targeted alpha therapy, supporting optimized treatment planning and precise response assessment. Continued standardization and validation of imaging, reconstruction, and dosimetry workflows will be critical to translate these approaches into reproducible, patient-specific clinical care. Full article

Background: Sinonasal neuroendocrine carcinoma (SNEC) is an extremely rare malignancy, and, to date, no clinical reports have detailed the use of proton beam therapy (PBT) for this disease. The present study describes the clinical courses of patients with SNEC treated with PBT and highlights the advantages of PBT. Methods: In this retrospective study, we included patients with pathologically confirmed SNEC without distant metastasis who underwent PBT at our institution between 2006 and 2021. To evaluate the dosimetric advantages of PBT, comparative treatment plans using VMAT were created. Result: Six patients with pathologically diagnosed SNEC without distant metastasis were treated with PBT. Multimodal treatment was applied in five patients, including chemotherapy in four cases and surgery in two cases. The median follow-up period was 37.4 months (range: 6.9 to 108.9 months). At the end of the follow-up, three patients were alive without recurrence, while three had died due to the disease. Recurrence occurred in three cases: one local recurrence, one in cervical lymph nodes, and two distant metastases. A late adverse event of Grade 4 vision decrease was observed in one patient on the ipsilateral side. Compared with VMAT, PBT lowered the average brain dose (median 3.3 Gy (RBE) vs. 12.6 Gy), brainstem D2 cc (10.7 Gy (RBE) vs. 34.9 Gy) and contralateral optic nerve D0.1 cc (47.6 Gy (RBE) vs. 63.3 Gy), while doses to the ipsilateral optic pathway were comparable. Conclusions: PBT in multimodal treatment achieved feasible local control for SNEC. The dose-sparing effect of PBT was more evident in organs distant from the target, although careful consideration is required for adjacent structures. Full article

Protons are conventionally regarded as a low-linear energy transfer (low-LET) radiation modality with a relative biological effectiveness (RBE) of 1.1, suggesting direct mechanistic similarity to X-rays in the underpinning biological effects. However, exposure to spread-out Bragg peak (SOBP) protons reveals instructive deviations from this assumption. Indeed, proton beams have a maximum LET of ~5 keV/µm but display reduced reliance on classical non-homologous end joining (c-NHEJ) as well as an increased dependence on homologous recombination (HR) and alternative end joining (alt-EJ). These features are well described in cells exposed to high-LET radiation and typically manifest between 100 and 150 keV/µm. We hypothesized that this apparent discrepancy reflects biological consequences of proton-beam properties that remain uncharacterized. In the present study, we outline exploratory experiments aiming at uncovering such mechanisms. We begin by investigating for both entrance and SOBP protons the dose-dependent engagement of HR we recently showed for X-rays. Consistent with our previous findings with X-rays, HR engagement after exposure to both types of proton beams declined with dose, from ~80% at 0.2 Gy to less than 20% at higher doses. RAD51/γH2AX foci ratios, reflecting HR engagement, were modestly higher following proton irradiation, in line with increased HR utilization. G₂-checkpoint activation, previously linked to HR, was also stronger after exposure to protons, as was DNA end resection. Moreover, the formation of structural chromosomal abnormalities (SCAs) was higher for SOBP than entrance protons and X-rays. Collectively, our results suggest quasi-high-LET characteristics for proton beams and raise the question as to the physical proton properties that underpin them. We discuss that the commonly employed definition of LET may be insufficient for this purpose. Full article

Traditional diode-based rectifiers (TDRs) in railway traction substations (TSSs) are inefficient at handling bidirectional power flow and cannot recover regenerative braking energy (RBE). Replacing these conventional systems with reversible traction substations (RTSSs) requires detailed modeling, extensive simulations, and validation using real data. This paper presents a DT-oriented real-time modeling and Hardware-in-the-Loop (HIL) platform for the analysis and performance assessment of RTSSs in DC railway systems. The integration of interleaved PWM rectifiers enables bidirectional power flow, allowing efficient RBE recovery and its return to the main grid. Modeling railway networks with moving trains is complex due to nonlinear dynamics arising from continuously varying positions, speeds, and accelerations. The proposed approach introduces an innovative multi-train simulation method combined with low-level transient and power-quality analysis. The validated DT model, supported by HIL emulation using OPAL-RT, accurately reproduces real-world system behavior, enabling optimal component sizing and evaluation of key performance indicators such as voltage ripple, total harmonic distortion, passive-component stress, and current imbalance. The results demonstrate improved energy efficiency, enhanced system design, and reduced operational costs. Meanwhile, experimental validation on a small-scale RTSS prototype, based on data from the Italian 3 kV DC railway system, confirms the accuracy and applicability of the proposed DT-oriented framework. Full article

Because of the advancement of IT, cross-domain environments have emerged where independent clouds with different security policies share data. However, sharing data between clouds with heterogeneous security levels is a challenging task, and most existing access control schemes focus on a single cloud domain. Among various access control models, RBAC is suitable for cross-domain data sharing, but existing RBAC schemes cannot provide strong role privacy and do not support freshness in role verification, so they are vulnerable to replay-based misuse of credentials. In this paper, we propose an RBAC scheme for cross-domain cloud environments based on a hash-chain-augmented zk-SNARK and identity-based signatures. The TA issues IBS-based role signing keys to users, and the user proves, through a zk-SNARK circuit, that there exists a valid role signing key satisfying the access policy without revealing the concrete role information to the CDS. In addition, a synchronized hash chain between the user and the CDS is embedded into the proof so that each proof is tied to the current hash-chain state and any previously used proof fails verification when replayed. We formalize role privacy, replay resistance, and MitM resistance in the cross-domain setting and analyze the proposed scheme by comparing it with Saxena and Alam’s I-RBAC, Xu et al.’s RBAC, MO-RBE, and PE-RBAC. The security analysis shows that the proposed scheme achieves robust role privacy against both the CDS and external attackers and prevents replay and man-in-the-middle attacks. Furthermore, the computational cost evaluation based on the number of pairing, exponentiation, point addition, and hash operations confirms that the verifier-side overhead remains comparable to existing schemes, while the additional prover cost is the price for achieving stronger privacy and security. Therefore, the proposed scheme can be applied to cross-domain cloud systems that require secure and privacy-preserving role verification, such as military, healthcare, and government cloud infrastructures. Full article